Alvin N. Kotake

804 total citations
27 papers, 663 citations indexed

About

Alvin N. Kotake is a scholar working on Clinical Biochemistry, Pharmacology and Physiology. According to data from OpenAlex, Alvin N. Kotake has authored 27 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Clinical Biochemistry, 7 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in Alvin N. Kotake's work include Metabolism and Genetic Disorders (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Diet and metabolism studies (5 papers). Alvin N. Kotake is often cited by papers focused on Metabolism and Genetic Disorders (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Diet and metabolism studies (5 papers). Alvin N. Kotake collaborates with scholars based in United States, Switzerland and Canada. Alvin N. Kotake's co-authors include Dale A. Schoeller, George H. Lambert, Alfred L. Baker, Yoshihiko Funae, Gilbert J. Mannering, Deborah Hay, Theodore C. Spaulding, A.E. Takemori, Elizabeth H. Jeffery and Earl G. Burton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and Biochemical Journal.

In The Last Decade

Alvin N. Kotake

27 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alvin N. Kotake United States 16 259 132 98 84 76 27 663
EA Sotaniemi Finland 13 265 1.0× 130 1.0× 98 1.0× 69 0.8× 42 0.6× 23 570
Bo Andersson Sweden 17 289 1.1× 262 2.0× 136 1.4× 68 0.8× 72 0.9× 30 791
J.F. Ménez France 19 416 1.6× 270 2.0× 128 1.3× 75 0.9× 102 1.3× 42 1.2k
P M Bélanger Canada 18 359 1.4× 197 1.5× 145 1.5× 140 1.7× 107 1.4× 50 888
Walid A. Al-Turk United States 14 135 0.5× 181 1.4× 49 0.5× 67 0.8× 73 1.0× 40 609
Monique Vincent‐Viry France 18 200 0.8× 327 2.5× 101 1.0× 64 0.8× 168 2.2× 40 1.0k
C. Girre France 18 401 1.5× 226 1.7× 133 1.4× 104 1.2× 63 0.8× 41 996
Jean‐François Ménez France 14 388 1.5× 190 1.4× 125 1.3× 87 1.0× 47 0.6× 23 760
G. Thomas Passananti United States 19 401 1.5× 206 1.6× 147 1.5× 185 2.2× 107 1.4× 39 1.1k
W Klinger Germany 18 400 1.5× 257 1.9× 218 2.2× 63 0.8× 138 1.8× 158 1.2k

Countries citing papers authored by Alvin N. Kotake

Since Specialization
Citations

This map shows the geographic impact of Alvin N. Kotake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alvin N. Kotake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alvin N. Kotake more than expected).

Fields of papers citing papers by Alvin N. Kotake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alvin N. Kotake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alvin N. Kotake. The network helps show where Alvin N. Kotake may publish in the future.

Co-authorship network of co-authors of Alvin N. Kotake

This figure shows the co-authorship network connecting the top 25 collaborators of Alvin N. Kotake. A scholar is included among the top collaborators of Alvin N. Kotake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alvin N. Kotake. Alvin N. Kotake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ermer, James, H. Lee, William DeMaio, et al.. (2003). Bazedoxifene Acetate Metabolic Disposition in Healthy, Postmenopausal Women. Clinical Pharmacology & Therapeutics. 73(2). 15 indexed citations
2.
Yenari, Midori A., et al.. (1998). Dose escalation safety and tolerance study of the competitive NMDA antagonist selfotel (CGS 19755) in neurosurgery patients.. PubMed. 21(1). 28–34. 24 indexed citations
3.
Rakhit, Ashok, D. I. Jones, Alvin N. Kotake, et al.. (1990). Pharmacokinetic Screening of o-Naphthoquinone 5-Lipoxygenase Inhibitors. Pharmaceutical Research. 7(10). 1071–1076. 4 indexed citations
4.
Lambert, George H., Dale A. Schoeller, Harold E. B. Humphrey, et al.. (1990). The caffeine breath test and caffeine urinary metabolite ratios in the Michigan cohort exposed to polybrominated biphenyls: a preliminary study.. Environmental Health Perspectives. 89. 175–181. 38 indexed citations
5.
Kotake, Alvin N., et al.. (1990). Effects of CGS-15943A on the relaxations produced by adenosine analogs in human blood vessels. European Journal of Pharmacology. 187(3). 525–530. 8 indexed citations
6.
Kotake, Alvin N., et al.. (1989). Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans. Xenobiotica. 19(11). 1247–1254. 53 indexed citations
7.
Fedorak, Richard N., Alvin N. Kotake, Frank L. Douglas, & Eugene B. Chang. (1989). Inhibition of Cholera-Toxin-Stimulated Intestinal Secretion by CGS 9343B in Rats. Journal of Pediatric Gastroenterology and Nutrition. 8(2). 252–258. 4 indexed citations
8.
Baker, Alfred L., et al.. (1987). The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis. Hepatology. 7(3). 464–467. 24 indexed citations
9.
Schoeller, Dale A., et al.. (1986). Effects of dietary protein on theophylline pharmacokinetics and caffeine and aminopyrine breath tests. Clinical Pharmacology & Therapeutics. 40(2). 187–194. 33 indexed citations
10.
Lambert, George H., et al.. (1986). The Effect of Age, Gender, and Sexual Maturation on the Caffeine Breath Test. Developmental Pharmacology and Therapeutics. 9(6). 375–388. 69 indexed citations
11.
Bornheim, Lester M., Alvin N. Kotake, & M.A.S. Correia. (1985). Differential haemin-mediated restoration of cytochrome P-450 N-demethylases after inactivation by allylisopropylacetamide. Biochemical Journal. 227(1). 277–286. 20 indexed citations
12.
Kotake, Alvin N., et al.. (1982). The caffeine CO2 breath test: Dose response and route of N-demethylation in smokers and nonsmokers. Clinical Pharmacology & Therapeutics. 32(2). 261–269. 85 indexed citations
13.
Kotake, Alvin N. & Renate Starr. (1982). The in vivo evaluation of the effect of age and sex on the developmental profile of aminopyrine N-demethylase activity in the newborn rat.. Drug Metabolism and Disposition. 10(3). 259–263. 4 indexed citations
15.
Kotake, Alvin N.. (1981). Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system. Biochemical Pharmacology. 30(17). 2473–2479. 1 indexed citations
16.
Jeffery, Elizabeth H., Alvin N. Kotake, Rokea A. el‐Azhary, & Gilbert J. Mannering. (1977). Effects of Linoleic Acid Hydroperoxide on the Hepatic Monooxygenase Systems of Microsomes from Untreated, Phenobarbital-Treated, and 3-Methylcholanthrene-Treated Rats. Molecular Pharmacology. 13(3). 415–425. 41 indexed citations
17.
Wattenberg, Lee W., et al.. (1976). Effects of antioxidants on metabolism of aromatic polycyclic hydrocarbons. Advances in Enzyme Regulation. 14. 313–322. 13 indexed citations
18.
Spaulding, Theodore C., Alvin N. Kotake, & A.E. Takemori. (1976). Microsomal spectral properties and narcotic N-demethylase activity in methadone-dependent rats.. Drug Metabolism and Disposition. 4(1). 45–52. 11 indexed citations
19.
Deloria, Laurel B., Thomas M. Guenthner, Elizabeth H. Jeffery, et al.. (1976). Comparison of hepatic microsomal drug-metabolizing systems from rats fed crude and purified diets.. Drug Metabolism and Disposition. 4(3). 215–222. 8 indexed citations
20.
Spaulding, Theodore C., et al.. (1974). THE EFFECT OF DIAZEPAM ON THE METABOLISM OF METHADONE BY THE LIVER OF METHADONE-DEPENDENT RATS. Drug Metabolism and Disposition. 2(5). 458–463. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026